Breaking News, Promotions & Moves

ShangPharma Appoints CSO

Taveras brings extensive experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Art Taveras has been appointed president and chief scientific officer at ShangPharma Corp. Dr. Taveras brings extensive pharmaceutical leadership and technical expertise in drug discovery, chemistry R&D and pharmaceutical development, having held executive roles at pharma and biopharma companies during his 24-year career.     Prior to joining the company, Dr. Taveras served as vice president Small Molecules Drug Discovery, vice president Chemistry R&D, and vice president CMC Developm...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters